Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Phio Pharmaceuticals › CEO received an award of 400K PHIO shares
Why it stands out Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Sep 28, 2026
Reporting period Not applicable
Filed with the SEC Sep 29, 2026 CEO Grant / award
Context Classification grant award
Code A — grant or award
Planned / mechanical clue Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID 0001683168-26-007483
Filed / recorded
Sep 29, 2026, 8:01 PM UTC
Added to OQRO Oct 8, 2026, 2:22 AM UTC
Data quality Verified: identifiers matched exactly
Issuer Phio Pharmaceuticals Corp.
Reporting person Robert J Bitterman
Relationship Director, Officer
Officer title Chairman, Pres. & CEO
Security Common Stock, $.0001 par value
Table Non-derivative (Table I)
Transaction date Sep 28, 2026
Acquired / disposed Acquired (A)
Shares owned after 764,871
Footnotes from the filing Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant. Includes shares of common stock underlying unvested restricted stock units.
Around the same time Insider buying
Traded Sep 29 · filed 1 day later
A Phio Pharmaceuticals director paid $5.2K out of pocket for Phio Pharmaceuticals shares. 2 other people at Phio Pharmaceuticals bought some too, in the same month. Shares held went up 14% with this purchase.
Insider buying
3 insiders in a week, 2nd time since 2013 Traded Sep 28 · filed 2 days later
A Phio Pharmaceuticals director paid $5.2K out of pocket for Phio Pharmaceuticals shares. 2 other people at Phio Pharmaceuticals bought some too, in the same month. Shares held went up 16% with this purchase.
Insider filing
Traded Sep 28 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Aug 6, 2026 Company filing · Form 8-K · Results Reported its results Aug 18, 2026 Insider CEO purchased ~$11K of PHIO shares in the open market Aug 19, 2026 Insider · Largest insider buy since 2013 Director purchased ~$17K of PHIO shares in the open market Sep 15, 2026 Insider · 13 days before an 8-K Director purchased ~$12K of PHIO shares in the open market Sep 22, 2026 Insider · 6 days before an 8-K CEO purchased ~$2.1K of PHIO shares in the open market Sep 24, 2026 Insider · 4 days before an 8-K Director purchased ~$6.6K of PHIO shares in the open market Sep 28, 2026 Company filing · Form 8-K · Executive change, Shareholder vote Changed a top executive or board member, and held a shareholder vote “Phio Pharmaceuticals Corp. (the “Company”) held its 2026 Annual Meeting of Stockholders via live webcast (the “Annual Meeting”) on September 28, 2026.” Sep 28, 2026 Insider · 3 insiders in a week, 2nd time since 2013 Director purchased ~$5.2K of PHIO shares in the open market What came next Sep 29, 2026 Insider Director purchased ~$5.2K of PHIO shares in the open market Nov 5, 2026 Company filing · Form 8-K · Results Reported its results Nov 9, 2026 Insider · 2 people Insiders: 2 purchases (~$36K) Nov 10, 2026 Insider · 3 insiders in a week, 3rd time since 2013 Director purchased ~$5.7K of PHIO shares in the open market